Revvity, Inc. (RVTY) — Fair Value Analysis
Base-case fair value (P50): $95.82 · Current price: $93.97 · Verdict: Fairly Valued
The Verdict on RVTY
Based on our Monte Carlo simulations, Revvity (RVTY) is currently Fairly Valued. Trading at a current price of $101.75, our median fair value (P50) stands at $106.73. This implies a +4.9% potential upside to the median, positioning RVTY squarely within a reasonable valuation range. Our analysis, which models thousands of forward scenarios to determine a comprehensive fair value distribution, suggests that at its present level, the market price largely reflects the underlying fundamentals of this Healthcare sector company. This finding provides a critical anchor for investors evaluating entry or exit points without significant immediate mispricing.
How RVTY stacks up against Healthcare
Revvity's operational and financial health is currently assessed as average when compared against its Healthcare sector peers. This average quality tier indicates that while RVTY maintains a solid operational footing, it does not significantly outperform or underperform its industry rivals in key metrics. An average quality tier suggests stable, but not exceptional, financial performance relative to the sector, reinforcing the Fairly Valued assessment derived from our median fair value of $106.73 versus the current price of $101.75. Investors should consider this relative positioning when assessing long-term growth potential and risk.
What this means for investors
For investors eyeing Revvity (RVTY), the Fairly Valued verdict, paired with an average quality tier, suggests a balanced risk-reward profile at the current price of $101.75. While the +4.9% implied upside to our median fair value of $106.73 offers some headroom, significant undervaluation is not present. This environment typically favors long-term holders or those focused on sector-specific trends rather than rapid valuation-driven gains. Understanding the full spectrum of potential outcomes, from downside scenarios to more optimistic bull cases, is crucial. FairCurve provides the complete Monte Carlo distribution for RVTY, offering deeper insights beyond the median. Sign up for FairCurve to see the full bear/bull distribution and track RVTY's fair value as new fundamentals are released.
Frequently Asked Questions
Is RVTY overvalued or undervalued right now?
Based on our Monte Carlo simulations, Revvity (RVTY) is currently fairly valued. Its current price of $101.75 is slightly below our median fair value (P50) of $106.73.
What is the bear case and bull case for RVTY?
The full Monte Carlo distribution, including bear (P10) and bull (P90) targets, alongside the probability of upside, is available with a free FairCurve account. We do not provide specific dollar values here.
How does FairCurve calculate RVTY's fair value?
FairCurve calculates RVTY's fair value by running Monte Carlo simulations over thousands of forward scenarios, evaluating potential future financial outcomes to determine a comprehensive valuation range.
How can I track RVTY's fair value as it changes?
Add RVTY to your free FairCurve watchlist to receive daily fair-value updates and instant re-valuation whenever new earnings or significant fundamental data are released.